Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

Vertigo: later-stage trial registry

2 of 6 indexed Vertigo trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Vertigo: 6 US clinical trials tracked, 2 recruiting.

Vertigo is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Otolith Labs, running 1 of these trials.

Enrollment posture brief

Registry condition vertigo

OPEN 2 | RECR 33% | LATE 1 | EARLY 0 | RANK #2866 | SPON 1

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Vertigo (this)33%
Open-enrollment share among volume-matched conditions near Vertigo

Vertigo lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Vertigo on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Vertigo is recruiting below its size-band peers.

    2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Vertigo research.

    Otolith Labs accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Vertigo enrolment sits around 100 participants.

    Median target enrolment is 100 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.

  4. Vertigo research is mostly interventional.

    6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on Vertigo records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Sham B Device
1 trials
Sham A Device
1 trials
Otoband Device
1 trials
Standard Care Control Behavioral
1 trials
Gaze and Postural Stability Behavioral
1 trials
Study Developed Educational Materials for Patients Behavioral
1 trials
CME Educational Intervention Behavioral
1 trials
Rate of Entry Behavioral
1 trials

US sites by state

Facility locations filed on Vertigo trials. A trial with sites in several states counts in each.

California 3 trials
Utah 1 trials
Maryland 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Vertigo page

6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Vertigo condition card totals 6 registered trials; most-linked intervention Sham B; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.